Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHeat Biologics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/16/2022 | Q1 2022 | -$0.49 | -$0.32 | 0.17 | N/A | $212,418 |
| 03/11/2022 | Q4 2021 | -$0.32 | -$0.54 | -0.22 | N/A | $-347,961 |
| 11/10/2021 | Q3 2021 | -$0.30 | -$0.30 | 0 | N/A | $501,567 |
| 08/11/2021 | Q2 2021 | -$0.30 | -$0.26 | 0.04 | N/A | $459,494 |
| 05/14/2021 | Q1 2021 | N/A | -$0.31 | N/A | N/A | $538,645 |
| 03/25/2021 | Q4 2020 | -$0.35 | -$0.27 | 0.08 | N/A | $603,192 |
| 11/09/2020 | Q3 2020 | -$0.23 | -$0.43 | -0.2 | N/A | $849,732 |
| 08/07/2020 | Q2 2020 | -$0.66 | -$0.35 | 0.31 | N/A | $593,165 |
| 05/15/2020 | Q1 2020 | -$0.70 | -$0.77 | -0.07 | N/A | $901,880 |
| 03/30/2020 | Q4 2019 | N/A | -$0.41 | N/A | N/A | $2.00 M |
| 11/14/2019 | Q3 2019 | -$1.01 | -$1.29 | -0.28 | N/A | $6,439 |
| 08/14/2019 | Q2 2019 | -$0.77 | -$1.00 | -0.23 | N/A | $342,487 |
| 05/15/2019 | Q1 2019 | -$1.36 | -$1.20 | 0.16 | N/A | $701,062 |
| 03/28/2019 | Q4 2018 | -$1.36 | -$1.04 | 0.32 | N/A | $2.06 M |
| 11/14/2018 | Q3 2018 | -$0.21 | -$1.11 | -0.9 | N/A | $1.84 M |
| 08/14/2018 | Q2 2018 | -$0.18 | -$1.92 | -1.74 | N/A | $0 |
| 05/15/2018 | Q1 2018 | N/A | -$5.24 | N/A | N/A | $752,527 |
| 03/02/2018 | Q4 2017 | -$0.70 | -$4.66 | -3.96 | N/A | $613,630 |
| 11/13/2017 | Q3 2017 | -$0.90 | -$4.44 | -3.54 | N/A | $470,823 |
| 08/14/2017 | Q2 2017 | -$1.00 | -$6.31 | -5.31 | N/A | $411,250 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Heat Biologics, Inc. Earnings: FAQ's
Heat Biologics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 16th, 2022 based offlast year's report dates.
In the previous quarter, Heat Biologics, Inc. (:HTBX) reported $-0.32471 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.49 by $0.16529.
The conference call for Heat Biologics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Heat Biologics, Inc.'s latest earnings report can be read online.
Heat Biologics, Inc. (:HTBX) has a recorded annual revenue of $2.11 M.
Heat Biologics, Inc. (:HTBX) has a recorded net income of $-35,400,807.Heat Biologics, Inc. has generated $-1.41 earnings per share over the last four quarters.
Heat Biologics, Inc. (:HTBX) has a price-to-earnings ratio of -1.69 and price/earnings-to-growth ratio is -0.02.